I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Characterization of the T cell receptor repertoire and mela..:
Ellingsen, Espen Basmo
;
Bounova, Gergana
;
Kerzeli, Iliana Kyriaki
...
Journal of Translational Medicine, 1479-5876, 2022, 20,. , 2022
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485339
RT Journal T1
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
UL https://suche.suub.uni-bremen.de/peid=base-ftuppsalauniv:oai:DiVA.org:uu-485339&Exemplar=1&LAN=DE A1 Ellingsen, Espen Basmo A1 Bounova, Gergana A1 Kerzeli, Iliana Kyriaki A1 Anzar, Irantzu A1 Simnica, Donjete A1 Aamdal, Elin A1 Guren, Tormod A1 Clancy, Trevor A1 Mezheyeuski, Artur A1 Inderberg, Else Marit A1 Mangsbo, Sara A1 Binder, Mascha A1 Hovig, Eivind A1 Gaudernack, Gustav PB Uppsala universitet, Science for Life Laboratory, SciLifeLab; Uppsala universitet, Institutionen för farmaci; Norwegian Radium Hosp, Dept Tumor Biol, Inst Canc Res, Oslo, Norway.;Univ Oslo, Fac Med, Oslo, Norway.;Ultimovacs ASA, Oslo, Norway.; ENPICOM BV, Da S Hertogenbosch, Netherlands.; NEC Oncoimmun, Oslo, Norway.; Univ Klinikum Halle Saale, Dept Internal Med Hematol & Oncol 4, Halle, Germany.; Oslo Univ Hosp, Dept Oncol, Oslo, Norway.; HistoOne AB, Uppsala, Sweden.; Oslo Univ Hosp, Dept Cellular Therapy, Oslo, Norway.; Ultimovacs AB, Uppsala, Sweden.; Norwegian Radium Hosp, Dept Tumor Biol, Inst Canc Res, Oslo, Norway.;Univ Oslo, Ctr Bioinformat, Oslo, Norway.; Ultimovacs ASA, Oslo, Norway. YR 2022 K1 Cancer K1 Immunotherapy K1 Therapeutic Cancer Vaccine K1 Telomerase K1 hTERT K1 Melanoma K1 Ipilimumab K1 Cancer and Oncology K1 Cancer och onkologi JF Journal of Translational Medicine, 1479-5876, 2022, 20, LK http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485339 DO http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485339 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)